Cell-based anti-cancer compositions and methods of making and using the same
OwnerScott A. Waldman, Adam E. Snookinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerScott A. Waldman, Adam E. Snookinventors
Estimating the term…
Isolated pluralities of T cells which recognize at least one epitope of a mucosally restricted antigen and pharmaceutical compositions comprising the same are disclosed. Methods of making a plurality of T cells that recognize at least one epitope of a mucosally restricted antigen are also disclosed. Methods of treating an individual who has been diagnosed with cancer of a mucosal tissue or preventing such cancer in an individual at elevated risk are disclosed as are nucleic acid molecules that comprise a nucleotide sequence that encode proteins that recognize at least one epitope of a mucosally restricted antigen and T cells comprising such nucleic acid molecules.
1-55. (canceled)
An isolated plurality of T cells which recognize at least one epitope of a mucosally restricted antigen, wherein said T cells are derived from clonal expansion of T cells that are isolated from an individual and transformed with a nucleic acid molecule which encodes a mucosally restricted antigen-binding membrane-bound fusion protein, and wherein the mucosally restricted antigen is selected from the group consisting of guanylyl cyclase C, sucrase isomaltase, CDX1, CDX2, mammoglobin, and small breast epithelial mucin.
A method of making a plurality of T cells that recognize at least one epitope of a mucosally restricted antigen, the method comprising the steps of:
A nucleic acid molecule comprising a nucleotide sequence that encodes a mucosally restricted antigen-binding membrane-bound fusion protein, wherein the mucosally restricted antigen is selected from the group consisting of guanylyl cyclase C, sucrase isomaltase, CDX1, CDX2, mammoglobin, and small breast epithelial mucin.
Dependencies are inferred from the claim text.